Vitamin D3 Spray für Kinder - besonders bioverfügbar

Vitamin D3 Spray für Kinder - besonders bioverfügbar

Marsoni

M251S

$13.95

Get it in 3 business days with 1 day shipping. Friday, May 29

Vitamin D3 Spray für Kinder - besonders bioverfügbarDas Vitamin D3 Spray ist speziell fr die Bedrfnisse von Kindern ab drei Jahren entwickelt. Es untersttzt die gesunde Entwicklung von Immunsystem, Knochen und Muskeln durch eine optimale Dosierung von Vitamin D3 nach den Vorgaben der DGE. Das Spray ist vegetarisch, zuckerfrei und frei von Gluten, Laktose und Allergenen. Mit seinem natrlichen Erdbeeraroma schmeckt es besonders angenehm. Einfach in der Anwendung, liefert es die empfohlene Tagesdosis an

Easy Shipping

Quick Dispatch:

Your Vitamin D3 Spray für Kinder - besonders bioverfügbar orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Vitamin D3 Spray für Kinder - besonders bioverfügbar ships.

Need Help?
Questions about Vitamin D3 Spray für Kinder - besonders bioverfügbar, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Vitamin D3 Spray für Kinder - besonders bioverfügbar in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

Very nice product very concentrated has a very light fragrance that dissipates very quickly not greasy. No I do not have any redness or sensitivity I wanted to try this product anyway because I'm always looking for moderately priced good quality that travels well. And this fit the bill especially with it being on sale.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on January 8, 2026